Microbiota restoration therapy (MRT) compositions and methods of manufacture
Microbiota restoration therapy (MRT) compositions (e.g., oral MRT compositions) and methods for manufacturing MRT compositions are disclosed. An example method for manufacturing an MRT composition may include collecting a stool sample, purifying the stool sample to form a purified sample, stabilizing the purified sample to form a stabilized sample, converting the stabilized sample to a solid, adding one or more additives and/or excipients to the solid to form a treatment composition, and encapsulating the treatment composition.
1. A packaged pharmaceutical product, comprising:
a package;
one or more capsules disposed in the package; and
a lyophilized material disposed within each of the one or more capsules, the lyophilized material comprising:
fecal microbiota, and
a lyophilization excipient, wherein the lyophilization excipient comprises polyethylene glycol, and one or more selected from trehalose, sucrose, and glycerin.
2. The packaged pharmaceutical product of claim 1 , wherein the package comprises a blister pack.
3. The packaged pharmaceutical product of claim 1 , wherein the package includes an oxygen scavenger disposed in the package.
4. The packaged pharmaceutical product of claim 1 , wherein the package includes a desiccant disposed in the package.
5. The packaged pharmaceutical product of claim 1 , wherein the package comprises a metallized polyester/polyethylene bonded film.
6. The packaged pharmaceutical product of claim 1 , wherein the package has a vapor transmission rate of 0.02 gr/100 in 2 in 24 hours.
7. The packaged pharmaceutical product of claim 1 , wherein the package has an oxygen transmission rate of 0.0402 gr/100 in 2 in 24 hours.
8. The packaged pharmaceutical product of claim 1 , wherein the lyophilized material comprises a lyophilization excipient comprising two or more selected from trehalose, sucrose, and glycerin.
9. The packaged pharmaceutical product of claim 1 , wherein the lyophilized material comprises a lyophilization excipient comprising trehalose, sucrose, and glycerin.
10. A packaged pharmaceutical product, comprising:
a metallized film package;
a plurality of capsules disposed in the metallized film package; and
a lyophilized material disposed within each of the capsules, the lyophilized material comprising:
fecal microbiota, and
a lyophilization excipient, wherein the lyophilization excipient comprises polyethylene glycol, and one or more selected from trehalose, sucrose, and glycerin.
11. The packaged pharmaceutical product of claim 10 , wherein the lyophilized material comprises a lyophilization excipient comprising two or more selected from trehalose, sucrose, and glycerin.
12. The packaged pharmaceutical product of claim 10 , wherein the lyophilized material comprises a lyophilization excipient comprising trehalose, sucrose, and glycerin.
13. A microbiota restoration therapy composition, comprising:
a capsule; and
a lyophilized material disposed within the capsule, the lyophilized material comprising fecal microbiota, and a lyophilization excipient comprising polyethylene glycol, trehalose, sucrose, and glycerin.
14. The microbiota restoration therapy composition of claim 13 , wherein the lyophilized material has a glass transition temperature greater than 30° C.
15. The microbiota restoration therapy composition of claim 13 , wherein the lyophilized material has a glass transition temperature in the range of 30-75° C.
16. The microbiota restoration therapy composition of claim 13 , wherein the capsule is disposed in a blister package.
17. The microbiota restoration therapy composition of claim 13 , wherein the capsule is disposed in a metallized film package.